Circulating Microparticles from Crohn’s Disease Patients Cause Endothelial and Vascular Dysfunctions

Geographical variability and environmental risk factors in inflammatory bowel disease

(2013) Siew C Ng et al.   GUT

Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project

(2012) Isabelle Cleynen et al.   GUT

Tissue factor exposing microparticles in inflammatory bowel disease

(2012) Julia Palkovits et al.   Journal of Crohns & Colitis

Microparticles as Regulators of Cardiovascular Inflammation

(2012) Ramaroson Andriantsitohaina et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles

(2011) Bence György et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Microparticles in Angiogenesis

(2011) M. Carmen Martinez et al.   CIRCULATION RESEARCH

Microvesicles: Intercellular Vectors of Biological Messages

(2011) S. Tual-Chalot et al.   MOLECULAR INTERVENTIONS

The role of bacteria and pattern-recognition receptors in Crohn's disease

(2011) Si Ming Man et al.   Nature Reviews Gastroenterology & Hepatology

Microparticles from Patients with Metabolic Syndrome Induce Vascular Hypo-Reactivity via Fas/Fas-Ligand Pathway in Mice

(2011) Abdelali Agouni et al.   PLoS One

Microparticles: targets and tools in cardiovascular disease

(2011) Maria Carmen Martinez et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Endothelial Dysfunction and Circulating Microparticles from Patients with Obstructive Sleep Apnea

(2010) Pascaline Priou et al.   AMERICAN JOURNAL OF PATHOLOGY

Microparticles

(2010) Sebastian F. Mause et al.   CIRCULATION RESEARCH

Increased platelet, leukocyte and endothelial microparticles predict enhanced coagulation and vascular inflammation in pulmonary hypertension

(2010) Philipp Diehl et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Endothelial-derived microparticles: Biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis

(2010) Aurélie Leroyer et al.   THROMBOSIS AND HAEMOSTASIS

Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel disease

(2009) Ioannis E. Koutroubakis et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), arginine, and 8-iso-prostaglandin F2α (8-iso-PGF2α) level in patients with inflammatory bowel diseases

(2009) Danuta Owczarek et al.   INFLAMMATORY BOWEL DISEASES

Inflammatory Bowel Disease

(2009) Clara Abraham et al.   NEW ENGLAND JOURNAL OF MEDICINE

Increased thrombin generation in inflammatory bowel diseases

(2009) Simone Saibeni et al.   THROMBOSIS RESEARCH

Endothelial Dysfunction Caused by Circulating Microparticles from Patients with Metabolic Syndrome

(2008) Abdelali Agouni et al.   AMERICAN JOURNAL OF PATHOLOGY

Circulating Microparticles from Patients with Septic Shock Exert Protective Role in Vascular Function

(2008) Hadj Ahmed Mostefai et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Evidence of Endothelial Dysfunction in Patients With Inflammatory Bowel Disease

(2008) Idan Roifman et al.   Clinical Gastroenterology and Hepatology

Vascular Involvement in Inflammatory Bowel Disease: Pathogenesis and Clinical Aspects

(2008) Alfredo Papa et al.   DIGESTIVE DISEASES

Biomarkers of altered coagulation and fibrinolysis as measures of disease activity in active inflammatory bowel disease: A gender-stratified, cohort analysis

(2008) Jun Shen et al.   THROMBOSIS RESEARCH